World News: 15:24 GMT Wednesday 11th July 2018. [Hoverink Biotechnologies, Inc via Globe Newswire via SPi World News]
LOS ANGELES CA July 11 2018 GLOBE NEWSWIRE -- HOVERINK BIOTECHNOLOGIES Appoints as its Hoverink Biotechnologies is currently developing IV and oral formulations of LADAVRUreg to treat chronic pain nausea and discomfort associated with che mothera...
Globe Newswire: 15:24 GMT Wednesday 11th July 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.